Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
16
pubmed:dateCreated
2007-4-5
pubmed:abstractText
We discovered a novel oncogene in a T-cell lymphoma cell line, multiple copies in T-cell lymphoma-1 (MCT-1), that has been shown to decrease cell-doubling time, shorten the duration of G(1) transit time and/or G(1)-S transition, and transform NIH3T3 fibroblasts. We subsequently demonstrated that there were significantly increased levels of MCT-1 protein in a subset of primary diffuse large B-cell lymphomas. Levels of MCT-1 protein were shown to be increased after exposure to DNA damaging agents. This increase did not require new protein synthesis, suggesting that post-translational mechanisms were involved. Phosphorylation is one potential mechanism by which the activity of molecules involved in cell cycle/survival is rapidly modulated. The RAS/mitogen-activated/extracellular-regulated kinase (MEK)/extracellular signal-regulated kinases (ERK) pathway plays a prominent role in the regulation of cell growth and proliferation through phosphorylation-dependent regulation of several substrates. The MCT-1 protein is predicted to have numerous putative phosphorylation sites. Using a combination of genetic and pharmacological approaches, we established that phosphorylation of MCT-1 protein by p44/p42 mitogen-activated protein kinases is critical for stabilization of MCT-1 protein and for its ability to promote cell proliferation. Our data suggests that targeting the RAS/MEK/ERK signal transduction cascade may provide a potential therapeutic approach in lymphomas and related malignancies that exhibit high levels of MCT-1 protein.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0950-9232
pubmed:author
pubmed:issnType
Print
pubmed:day
5
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2283-9
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:17016429-3T3 Cells, pubmed-meshheading:17016429-Amino Acid Sequence, pubmed-meshheading:17016429-Animals, pubmed-meshheading:17016429-Cell Cycle, pubmed-meshheading:17016429-Cell Cycle Proteins, pubmed-meshheading:17016429-Cell Division, pubmed-meshheading:17016429-Cell Line, Tumor, pubmed-meshheading:17016429-Cell Survival, pubmed-meshheading:17016429-DNA Damage, pubmed-meshheading:17016429-Humans, pubmed-meshheading:17016429-Jurkat Cells, pubmed-meshheading:17016429-Kinetics, pubmed-meshheading:17016429-Lymphoma, T-Cell, pubmed-meshheading:17016429-Mice, pubmed-meshheading:17016429-Mitogen-Activated Protein Kinase 1, pubmed-meshheading:17016429-Mitogen-Activated Protein Kinase 3, pubmed-meshheading:17016429-Molecular Sequence Data, pubmed-meshheading:17016429-Oncogene Proteins, pubmed-meshheading:17016429-Phosphorylation
pubmed:year
2007
pubmed:articleTitle
Phosphorylation of MCT-1 by p44/42 MAPK is required for its stabilization in response to DNA damage.
pubmed:affiliation
Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
pubmed:publicationType
Journal Article